srch

Blueprint Medicines Corp headquarters address, phone number and website information and details on other Blueprint Medicines Corp's locations and ...

Our research focuses on distinct areas where we believe we can significantly advance medicine and improve patient outcomes. Across these areas, we combine a rich universe of kinase targets with profound scientific, clinical and commercial expertise. Select one of our areas of focus below to learn more. Genomically defined cancers.

1 dag siden · About Blueprint Medicines Blueprint Medicines is a global precision therapy company that invents life-changing therapies for people with cancer and hematologic disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease.

GAVRETO is jointly commercialized in the U.S. by Blueprint Medicines and Genentech, a wholly owned member of the Roche Group, under Blueprint Medicines’ collaboration with Roche.

15.12.2021 · Blueprint Medicines Corporation (Nasdaq: BPMC) will acquire Lengo Therapeutics, a privately held precision oncology company based in San Diego, for $250 million in cash. The deal also includes up to $215 million in additional potential payments to Lengo based on meeting certain regulatory approval and sales-based milestones.

Dec 30, 2021 · About Blueprint Medicines. Blueprint Medicines is a global precision therapy company that invents life-changing therapies for people with cancer and hematologic disorders. Applying an approach that is both precise and agile, we create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of ...

Blueprint Medicines Office Locations ; Cambridge · US · 45 Sidney St ; Cambridge · US. 38 Sidney St #200 ; Amsterdam · NL. Gustav Mahlerplein 2 ; Lugano · CH. Via Emilio ...

1 day ago · CAMBRIDGE, Mass., Dec. 30, 2021 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that the company has successfully completed its previously announced acquisition of Lengo Therapeutics and lead compound LNG-451, a potential best-in-class oral precision therapy in development for the treatment of non-small cell lung cancer (NSCLC) in patients with EGFR exon 20 ...

Blueprint Medicines Overview · Website: www.blueprintmedicines.com · Headquarters: Cambridge, MA · Size: 201 to 500 Employees · Founded: 2011 · Type: Company - ...

Blueprint Medicines is a patient-driven oncology company discovering and developing highly selective kinase inhibitors for genomically defined cancers.

Blueprint Medicines is headquartered in Cambridge, MA and has 3 office locations across 2 countries. View Company Filter locations by country United States Switzerland All Blueprint …

02.09.2021 · Blueprint Medicines Office Locations Blueprint Medicines has offices in Cambridge, Amsterdam, Lugano and Zug Open Map View Cambridge, MA, US (HQ) 45 Sidney St Cambridge, MA, US 38 Sidney St #200 Amsterdam, NL Gustav Mahlerplein 2 Lugano, CH Via Emilio Bossi 6 Zug, CH Baarerstrasse 8 Show all (5) Report incorrect company information

Dec 10, 2021 · Blueprint Medicines Office Locations. Blueprint Medicines has offices in Cambridge, Amsterdam, Lugano and Zug. Open Map View. Cambridge, MA, US (HQ) 45 Sidney St. Cambridge, MA, US. 38 Sidney St #200. Amsterdam, NL. Gustav Mahlerplein 2.

At Blueprint Medicines, we work together in pursuit of one common goal: to dramatically improve the lives of people with genomically defined diseases.

Blueprint Medicines Global Headquarters. 45 Sidney Street. Cambridge, MA 02139. (617) 374-7580. info@blueprintmedicines.com. EU Office. Blueprint Medicines (Switzerland) GmbH. Baarerstrasse 8. 6300 Zug.

Company Description: Blueprint Medicines is a precision therapy company that identifies kinases that are drivers of genomically defined diseases and ...

Blueprint Medicines Appoints Daniella Beckman to its Board of Directors Dec 07, 2021 Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) More News Events and presentations Nov 29, 2021 Blueprint Medicines Conference Call Oct 28, 2021 Q3 2021 Blueprint Medicines Corp Conference Call More events and presentations

Blueprint Medicines Appoints Daniella Beckman to its Board of Directors Dec 07, 2021 Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) More News Events and presentations Nov 29, 2021 Blueprint Medicines Conference Call Oct 28, 2021 Q3 2021 Blueprint Medicines Corp Conference Call More events and presentations

21.12.2021 · Blueprint Medicines is a global precision therapy company that invents life-changing medicines for people with cancer and hematologic disorders. Applying an approach that is both precise and agile,...

Locations · Primary. 45 Sidney St. Cambridge, Massachusetts 02139, US. Get directions · Baarerstrasse 8. Zug, CH. Get directions ...